Assay Development Doctors Pharmacokinetics 
Drug Discovery World
JUNE 12, 2023
For instance, if there’s something unique biologically, we surround ourselves with doctors who give us a good insight that this is worth pursuing. With the publications of our other data, our Phase II work, the science has led to a lot of interest from doctors on behalf of their patients.
Drug Discovery World
FEBRUARY 15, 2023
Another widely available commercial model is the cell-line derived xenograft (CDX) 9 that involves inoculation of fast-growing tumour cell lines into immunodeficient mice for various applications including pharmacokinetics, efficacy of cell killing, and studying tumour metastasis by in vivo imaging.
Expert insights. Personalized for you.
130 
Let's personalize your content